Hyderabad-based vaccine maker says not including ICMR in original patent application for Covaxin was ‘inadvertent error’ & ‘confidential agreement between them was not accessible’.
Health ministry points at shortfall in supply of 3 vaccines, for Japanese Encephalitis, Hepatitis B & rotavirus. It also sought reason for delay in letter to Bharat Biotech.
Speaking at International Science Festival in Bhopal, Krishna Ella said iNCOVACC will be launched by 26 Jan and a vaccine for lumpy skin disease, too, will be launched next month.
The Union health ministry said that those who have previously taken Covishield and Covaxin could take the nasal vaccine as a heterologous booster dose.
Official sources clarifeid that masks were not mandatory yet. Congress’s Bharat Jodo Yatra can also continue provided it adhered to Covid protocols, they said.
Medical news site STAT had cited internal documents to allege that Bharat Biotech had taken ‘questionable’ steps under political pressure to speed up development of Covaxin.
Bharat Biotech is believed to have assured Government of India that it will ‘quickly’ reply to WHO about ‘deficiencies found in its manufacturing’ during an inspection last month.
ICMR and Bharat Biotech developed Covaxin together, and MoS Health Bharati Pawar says in written reply that the research body spent Rs 35 crore on its development.
India’s civil services were once called the ‘steel frame’. But steel is forged in fire, not moulded in a coaching class. While dilution has made the exam easier, it has also made it harder to find the game-changers we need.
SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.
Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.
COMMENTS